Financhill
Back

Apellis Pharmaceuticals Vs. Ionis Pharmaceuticals Industry Stock Comparison

Sell
33

APLS
Apellis Pharmaceuticals

Last Price:
26.19
Seasonality Move:
20.78%
Sell
31

IONS
Ionis Pharmaceuticals

Last Price:
33.74
Seasonality Move:
2.22%
Sell
33
Apellis Pharmaceuticals (APLS) is a Sell

Is Apellis Pharmaceuticals a Buy, Sell or Hold?

  • The current Apellis Pharmaceuticals [APLS] share price is $26.27. The Score for APLS is 33, which is 34% below its historic median score of 50, and infers higher risk than normal.
  • APLS is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
31
Ionis Pharmaceuticals (IONS) is a Sell

Is Ionis Pharmaceuticals a Buy, Sell or Hold?

  • The current Ionis Pharmaceuticals [IONS] share price is $34.34. The Score for IONS is 31, which is 38% below its historic median score of 50, and infers higher risk than normal.
  • IONS is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

APLS Stock Price Chart

What is Apellis Pharmaceuticals's stock price today?

  • The Apellis Pharmaceuticals share price today is $26.27
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and APLS is experiencing selling pressure, which indicates risk of future bearish movement.

IONS Stock Price Chart

What is Ionis Pharmaceuticals's stock price today?

  • The Ionis Pharmaceuticals share price today is $34.34
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and IONS is experiencing selling pressure, which indicates risk of future bearish movement.

APLS Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.4 Sell
Relative Strength Index (14 RSI): 36.3 Sell
Chaikin Money Flow: -4148679 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (27.02 - 28.78) Sell
Bollinger Bands (100): (29.08 - 39.08) Sell

IONS Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.87 Sell
Relative Strength Index (14 RSI): 26.91 Sell
Chaikin Money Flow: -1669523 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (37.48 - 39.66) Sell
Bollinger Bands (100): (39.34 - 48.46) Sell

APLS Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 28.63 Sell
20-day SMA: 27.95 Sell
50-day SMA: 30.19 Sell
200-day SMA: 43.29 Sell
8-day EMA: 28.09 Sell
20-day EMA: 28.31 Sell
50-day EMA: 30.23 Sell
200-day EMA: 40.03 Sell

IONS Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 37.84 Sell
20-day SMA: 38.52 Sell
50-day SMA: 39.79 Sell
200-day SMA: 43.26 Sell
8-day EMA: 37.33 Sell
20-day EMA: 38.28 Sell
50-day EMA: 40.03 Sell
200-day EMA: 42.91 Sell

Apellis Pharmaceuticals Earnings Growth & APLS Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.11 per share, a decrease next quarter of $0.00 per share, an increase this year of $2.75 per share, and an increase next year of $0.83 per share.

Ionis Pharmaceuticals Earnings Growth & IONS Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.06 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.07 per share, and an increase next year of $0.04 per share.

Apellis Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Ionis Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):